{"artifact":{"id":"paper-37532929","artifact_type":"paper","entity_ids":null,"title":"Pharmacological targeting of netrin-1 inhibits EMT in cancer.","quality_score":0.9,"created_by":"crosslink_script","provenance_chain":null,"content_hash":null,"metadata":{"_schema_version":1},"created_at":"2026-04-03T07:10:32-07:00","updated_at":"2026-04-16T22:06:44.126990-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"external","origin_url":"https://pubmed.ncbi.nlm.nih.gov/37532929/","lifecycle_changed_at":"2026-04-03T07:10:32-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"3d676f9e-8f52-4412-bb9b-de3c1915bad7","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"crosslink_script"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"hypothesis-h-05b8894a","link_type":"supports","strength":0.7,"evidence":"Evidence from PMID 37532929: Pharmacological targeting of netrin-1 inhibits EMT in cancer."}],"incoming_links":[{"source_artifact_id":"experiment-exp-047e9acb-1632-48fb-8206-5088129c6994","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"source_artifact_id":"experiment-exp-a6cf73af-6b06-42d2-9313-8f4ee944f7b7","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"source_artifact_id":"experiment-exp-a22c76d3-d586-4f64-be64-fa55688f609d","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"source_artifact_id":"experiment-exp-e55520c8-f578-4982-b9a6-efff4219f6d4","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"source_artifact_id":"experiment-exp-08833ef2-f2ab-4007-9aa7-5987cee656df","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"source_artifact_id":"hypothesis-h-05b8894a","link_type":"supports","strength":0.7,"evidence":"Evidence from PMID 37532929: Pharmacological targeting of netrin-1 inhibits EMT in cancer."}],"current_artifact_id":"paper-37532929","is_canonical":true,"supersede_chain":["paper-37532929"]}